Lataa...

Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer

Estrogen receptor α (ER) is the major driver of ∼75% of breast cancers, and multiple ER targeting drugs are routinely used clinically to treat patients with ER(+) breast cancer. However, many patients relapse on these targeted therapies and ultimately develop metastatic and incurable disease, and un...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Genes Dev
Päätekijät: Siersbæk, Rasmus, Kumar, Sanjeev, Carroll, Jason S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Cold Spring Harbor Laboratory Press 2018
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6120708/
https://ncbi.nlm.nih.gov/pubmed/30181360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gad.316646.118
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!